← Open Payments lookup

ROBERTA MOTT: Open Payments

NPI 1164052015 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$705 in 36 payments from 13 companies in 2025. Trend: 2023 $509 · 2024 $1,162 · 2025 $705

Food & beverage: $705
CompanyPaymentsAmount
Mallinckrodt Hospital Products Inc.2$146
Novartis Pharmaceuticals Corporation4$109
Travere Therapeutics, Inc.11$89
Calliditas Therapeutics US Inc.3$79
Bayer Healthcare Pharmaceuticals Inc.3$51
Otsuka America Pharmaceutical, Inc.3$50
AstraZeneca Pharmaceuticals LP3$49
Novo Nordisk Inc2$44
Takeda Pharmaceuticals U.S.A., Inc.1$22
OPKO Pharmaceuticals, LLC1$19

Products named: TERLIVAZ, TARPEYO, Fabhalta, Kerendia, JYNARQUE, Ozempic, FARXIGA, Vanrafia.

Industry payments across MO — which companies pay providers there.